Met Life Investment Management, LLC Edgewise Therapeutics, Inc. Transaction History
Met Life Investment Management, LLC
- $18.1 Billion
- Q1 2025
A detailed history of Met Life Investment Management, LLC transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Met Life Investment Management, LLC holds 43,883 shares of EWTX stock, worth $625,771. This represents 0.01% of its overall portfolio holdings.
Number of Shares
43,883
Previous 44,612
1.63%
Holding current value
$625,771
Previous $1.19 Million
18.98%
% of portfolio
0.01%
Previous 0.01%
Shares
13 transactions
Others Institutions Holding EWTX
# of Institutions
222Shares Held
105MCall Options Held
2.57MPut Options Held
1.58M-
Orbimed Advisors LLC San Diego, CA15MShares$214 Million10.3% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$127 Million4.07% of portfolio
-
Perceptive Advisors LLC New York, NY6.55MShares$93.4 Million6.03% of portfolio
-
Baker Bros. Advisors LP New York, NY6.16MShares$87.8 Million1.61% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$85.8 Million0.0% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $901M
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...